Richard Gelber

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Premenopause

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Rabaglio M; Sun Z; Price K N; Castiglione-Gertsch M; Hawle H; Thürlimann B; Mouridsen H; Campone M; Forbes J F; Paridaens R J; Colleoni M; Pienkowski T; Nogaret J-M; Láng I; Smith I; Gelber R D; Goldhirsch A; Coates A S;
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
Pagani Olivia; Price Karen N; Gelber Richard D; Castiglione-Gertsch Monica; Holmberg Stig B; Lindtner Jurij; Thürlimann Beat; Collins John; Fey Martin F; Coates Alan S; Goldhirsch Aron;
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Goldhirsch A; Ingle J N; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Gelber (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Rabaglio M; Sun Z; Price K N; Castiglione-Gertsch M; Hawle H; Thürlimann B; Mouridsen H; Campone M; Forbes J F; Paridaens R J; Colleoni M; Pienkowski T; Nogaret J-M; Láng I; Smith I; Gelber R D; Goldhirsch A; Coates A S;
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(9):1489-98.
2009: Pagani Olivia; Price Karen N; Gelber Richard D; Castiglione-Gertsch Monica; Holmberg Stig B; Lindtner Jurij; Thürlimann Beat; Collins John; Fey Martin F; Coates Alan S; Goldhirsch Aron;
Patterns of recurrence of early breast cancer according to estrogen receptor status: a therapeutic target for a quarter of a century.
Breast cancer research and treatment 2009;117(2):319-24.
2009: Goldhirsch A; Ingle J N; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1319-29.
2009: Colleoni M; Sun Z; Martinelli G; Basser R L; Coates A S; Gelber R D; Green M D; Peccatori F; Cinieri S; Aebi S; Viale G; Price K N; Goldhirsch A;
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1344-51.
2009: Pagani Olivia; Gelber Shari; Simoncini Edda; Castiglione-Gertsch Monica; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Collins John; Lindtner Jurij; Thürlimann Beat; Fey Martin F; Murray Elizabeth; Forbes John F; Coates Alan S; Goldhirsch Aron;
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
Breast cancer research and treatment 2009;116(3):491-500.
2009: Colleoni Marco; Bagnardi Vincenzo; Rotmensz Nicole; Gelber Richard D; Viale Giuseppe; Pruneri Giancarlo; Veronesi Paolo; Torrisi Rosalba; Cardillo Anna; Montagna Emilia; Campagnoli Elisabetta; Luini Alberto; Intra Mattia; Galimberti Viviana; Scarano Eloise; Peruzzotti Giulia; Goldhirsch Aron
Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.
Breast cancer research and treatment 2009;116(2):359-69.
2009: Giobbie-Hurder Anita; Price Karen N; Gelber Richard D;
Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer.
Clinical trials (London, England) 2009;6(3):272-87.
2009: Dowsett Mitch; Procter Marion; McCaskill-Stevens Worta; de Azambuja Evandro; Dafni Urania; Rueschoff Josef; Jordan Bruce; Dolci Stella; Abramovitz Mark; Stoss Oliver; Viale Giuseppe; Gelber Richard D; Piccart-Gebhart Martine; Leyland-Jones Brian
Disease-free survival according to degree of HER2 amplification for patients treated with adjuvant chemotherapy with or without 1 year of trastuzumab: the HERA Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):2962-9.
2009: Sun Zhuoxin; Goldhirsch Aron; Price Karen N; Colleoni Marco; Ravaioli Alberto; Simoncini Edda; Campbell Ian; Gelber Richard D; Towler Mark
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer.
Breast (Edinburgh, Scotland) 2009;18(2):84-8.
2009: Desmedt Christine; Giobbie-Hurder Anita; Neven Patrick; Paridaens Robert; Christiaens Marie-Rose; Smeets Ann; Lallemand Françoise; Haibe-Kains Benjamin; Viale Giuseppe; Gelber Richard D; Piccart Martine; Sotiriou Christos
The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial.
BMC medical genomics 2009;2():40.
2008: Viale Giuseppe; Giobbie-Hurder Anita; Regan Meredith M; Coates Alan S; Mastropasqua Mauro G; Dell'Orto Patrizia; Maiorano Eugenio; MacGrogan Gaëtan; Braye Stephen G; Ohlschlegel Christian; Neven Patrick; Orosz Zsolt; Olszewski Wojciech P; Knox Fiona; Thürlimann Beat; Price Karen N; Castiglione-Gertsch Monica; Gelber Richard D; Gusterson Barry A; Goldhirsch Aron;
Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(34):5569-75.
2008: Pestalozzi B C; Francis P; Quinaux E; Dolci S; Azambuja E; Gelber R D; Viale G; Balil A; Andersson M; Nordenskjöld B; Gnant M; Gutierrez J; Láng I; Crown J P A; Piccart-Gebhart M;
Is risk of central nervous system (CNS) relapse related to adjuvant taxane treatment in node-positive breast cancer? Results of the CNS substudy in the intergroup Phase III BIG 02-98 Trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(11):1837-41.
2008: Anderson James R; Cain Kevin C; Gelber Richard D
Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3913-5.
2008: Bonetti Marco; Cole Bernard F; Gelber Richard D
Another STEPP in the right direction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3813-4; author reply 3814-5.
2008: Gruber G; Cole B F; Castiglione-Gertsch M; Holmberg S B; Lindtner J; Golouh R; Collins J; Crivellari D; Thürlimann B; Simoncini E; Fey M F; Gelber R D; Coates A S; Price K N; Goldhirsch A; Viale G; Gusterson B A;
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(8):1393-401.
2008: Regan M M; Pagani O; Walley B; Torrisi R; Perez E A; Francis P; Fleming G F; Price K N; Thürlimann B; Maibach R; Castiglione-Gertsch M; Coates A S; Goldhirsch A; Gelber R D;
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(7):1231-41.
2008: Wapnir Irene L; Aebi Stefan; Geyer Charles E; Zahrieh David; Gelber Richard D; Anderson Stewart J; Robidoux André; Bernhard Jürg; Maibach Rudolf; Castiglione-Gertsch Monica; Coates Alan S; Piccart Martine J; Clemons Mark J; Costantino Joseph P; Wolmark Norman;
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
Clinical breast cancer 2008;8(3):287-92.
2008: Pestalozzi Bernhard C; Zahrieh David; Mallon Elizabeth; Gusterson Barry A; Price Karen N; Gelber Richard D; Holmberg Stig B; Lindtner Jurij; Snyder Raymond; Thürlimann Beat; Murray Elizabeth; Viale Giuseppe; Castiglione-Gertsch Monica; Coates Alan S; Goldhirsch Aron;
Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):3006-14.
2008: Untch M; Gelber R D; Jackisch C; Procter M; Baselga J; Bell R; Cameron D; Bari M; Smith I; Leyland-Jones B; de Azambuja E; Wermuth P; Khasanov R; Feng-Yi F; Constantin C; Mayordomo J I; Su C-H; Yu S-Y; Lluch A; Senkus-Konefka E; Price C; Haslbauer F; Suarez Sahui T; Srimuninnimit V; Colleoni M; Coates A S; Piccart-Gebhart M J; Goldhirsch A;
Estimating the magnitude of trastuzumab effects within patient subgroups in the HERA trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(6):1090-6.
2008: Rocca Andrea; Viale Giuseppe; Gelber Richard D; Bottiglieri Luca; Gelber Shari; Pruneri Giancarlo; Ghisini Raffaella; Balduzzi Alessandra; Pietri Elisabetta; D'Alessandro Claudia; Goldhirsch Aron; Colleoni Marco
Pathologic complete remission rate after cisplatin-based primary chemotherapy in breast cancer: correlation with p63 expression.
Cancer chemotherapy and pharmacology 2008;61(6):965-71.
2008: Crivellari Diana; Sun Zhuoxin; Coates Alan S; Price Karen N; Thürlimann Beat; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert J; Castiglione-Gertsch Monica; Gelber Richard D; Colleoni Marco; Láng István; Del Mastro Lucia; Gladieff Laurence; Rabaglio Manuela; Smith Ian E; Chirgwin Jacquie H; Goldhirsch Aron
Letrozole compared with tamoxifen for elderly patients with endocrine-responsive early breast cancer: the BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1972-9.
2008: Viale Giuseppe; Regan Meredith M; Maiorano Eugenio; Mastropasqua Mauro G; Golouh Rastko; Perin Tiziana; Brown Robert W; Kovács Anikó; Pillay Komala; Ohlschlegel Christian; Braye Stephen; Grigolato Piergiovanni; Rusca Tiziana; Gelber Richard D; Castiglione-Gertsch Monica; Price Karen N; Goldhirsch Aron; Gusterson Barry A; Coates Alan S
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(9):1404-10.
2008: Colleoni M; Viale G; Zahrieh D; Bottiglieri L; Gelber R D; Veronesi P; Balduzzi A; Torrisi R; Luini A; Intra M; Dellapasqua S; Cardillo A; Ghisini R; Peruzzotti G; Goldhirsch A
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2008;19(3):465-72.
2008: Viale Giuseppe; Regan Meredith M; Mastropasqua Mauro G; Maffini Fausto; Maiorano Eugenio; Colleoni Marco; Price Karen N; Golouh Rastko; Perin Tiziana; Brown R W; Kovács Anikó; Pillay Komala; Ohlschlegel Christian; Gusterson Barry A; Castiglione-Gertsch Monica; Gelber Richard D; Goldhirsch Aron; Coates Alan S;
Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer.
Journal of the National Cancer Institute 2008;100(3):207-12.
2008: Francis Prudence; Crown John; Di Leo Angelo; Buyse Marc; Balil Ana; Andersson Michael; Nordenskjöld Bo; Lang Istvan; Jakesz Raimund; Vorobiof Daniel; Gutiérrez Jorge; van Hazel Guy; Dolci Stella; Jamin Sophie; Bendahmane Belguendouz; Gelber Richard D; Goldhirsch Aron; Castiglione-Gertsch Monica; Piccart-Gebhart Martine;
Adjuvant chemotherapy with sequential or concurrent anthracycline and docetaxel: Breast International Group 02-98 randomized trial.
Journal of the National Cancer Institute 2008;100(2):121-33.
2008: Clarke M; Coates A S; Darby S C; Davies C; Gelber R D; Godwin J; Goldhirsch A; Gray R; Peto R; Pritchard K I; Wood W C
Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials.
Lancet 2008;371(9606):29-40.
2008: Rasmussen Birgitte B; Regan Meredith M; Lykkesfeldt Anne E; Dell'Orto Patrizia; Del Curto Barbara; Henriksen Katrine L; Mastropasqua Mauro G; Price Karen N; Méry Eliane; Lacroix-Triki Magali; Braye Stephen; Altermatt Hans J; Gelber Richard D; Castiglione-Gertsch Monica; Goldhirsch Aron; Gusterson Barry A; Thürlimann Beat; Coates Alan S; Viale Giuseppe;
Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.
The lancet oncology 2008;9(1):23-8.
2008: Bernhard J; Zahrieh D; Zhang J J; Martinelli G; Basser R; Hürny C; Forbes J F; Aebi S; Yeo W; Thürlimann B; Green M D; Colleoni M; Gelber R D; Castiglione-Gertsch M; Price K N; Goldhirsch A; Coates A S;
Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.
British journal of cancer 2008;98(1):25-33.
2007: Mouridsen Henning; Keshaviah Aparna; Coates Alan S; Rabaglio Manuela; Castiglione-Gertsch Monica; Sun Zhuoxin; Thürlimann Beat; Mauriac Louis; Forbes John F; Paridaens Robert; Gelber Richard D; Colleoni Marco; Smith Ian; Price Karen N; Goldhirsch Aron
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5715-22.
2007: Regan Meredith M; Gelber Richard D;
Using clinical trial data to tailor adjuvant treatments for individual patients.
Breast (Edinburgh, Scotland) 2007;16 Suppl 2():S98-104.
2007: Viale Giuseppe; Regan Meredith M; Maiorano Eugenio; Mastropasqua Mauro G; Dell'Orto Patrizia; Rasmussen Birgitte Bruun; Raffoul Johnny; Neven Patrick; Orosz Zsolt; Braye Stephen; Ohlschlegel Christian; Thürlimann Beat; Gelber Richard D; Castiglione-Gertsch Monica; Price Karen N; Goldhirsch Aron; Gusterson Barry A; Coates Alan S
Prognostic and predictive value of centrally reviewed expression of estrogen and progesterone receptors in a randomized trial comparing letrozole and tamoxifen adjuvant therapy for postmenopausal early breast cancer: BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3846-52.
2007: Suter Thomas M; Procter Marion; van Veldhuisen Dirk J; Muscholl Michael; Bergh Jonas; Carlomagno Chiara; Perren Timothy; Passalacqua Rodolfo; Bighin Claudia; Klijn Jan G M; Ageev Fail T; Hitre Erika; Groetz Juergen; Iwata Hiroji; Knap Malgorzata; Gnant Michael; Muehlbauer Susanne; Spence Alison; Gelber Richard D; Piccart-Gebhart Martine J
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3859-65.
2007: Goldhirsch A; Wood W C; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1133-44.
2007: Partridge Ann; Gelber Shari; Gelber Richard D; Castiglione-Gertsch Monica; Goldhirsch Aron; Winer Eric
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VI.
European journal of cancer (Oxford, England : 1990) 2007;43(11):1646-53.
2007: Colleoni Marco; Gelber Shari; Simoncini Edda; Pagani Olivia; Gelber Richard D; Price Karen N; Castiglione-Gertsch Monica; Coates Alan S; Goldhirsch Aron
Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1177-84.
2007: Hudis Clifford A; Barlow William E; Costantino Joseph P; Gray Robert J; Pritchard Kathleen I; Chapman Judith-Anne W; Sparano Joseph A; Hunsberger Sally; Enos Rebecca A; Gelber Richard D; Zujewski Jo Anne
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2127-32.
2007: Jordan V Craig; Gelber Richard D
Problems with the progesterone receptor in practice?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):1957-9.
2007: Karlsson Per; Cole Bernard F; Price Karen N; Coates Alan S; Castiglione-Gertsch Monica; Gusterson Barry A; Murray Elizabeth; Lindtner Jurij; Collins John P; Holmberg Stig B; Fey Martin F; Thürlimann Beat; Crivellari Diana; Forbes John F; Gelber Richard D; Goldhirsch Aron; Wallgren Arne
The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2019-26.
2007: Mauriac L; Keshaviah A; Debled M; Mouridsen H; Forbes J F; Thürlimann B; Paridaens R; Monnier A; Láng I; Wardley A; Nogaret J-M; Gelber R D; Castiglione-Gertsch M; Price K N; Coates A S; Smith I; Viale G; Rabaglio M; Zabaznyi N; Goldhirsch A;
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(5):859-67.
2007: Keshaviah A; Dellapasqua S; Rotmensz N; Lindtner J; Crivellari D; Collins J; Colleoni M; Thürlimann B; Mendiola C; Aebi S; Price K N; Pagani O; Simoncini E; Castiglione Gertsch M; Gelber R D; Coates A S; Goldhirsch A
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(4):701-8.
2007: Coates Alan S; Keshaviah Aparna; Thürlimann Beat; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert; Castiglione-Gertsch Monica; Gelber Richard D; Colleoni Marco; Láng István; Del Mastro Lucia; Smith Ian; Chirgwin Jacquie; Nogaret Jean-Marie; Pienkowski Tadeusz; Wardley Andrew; Jakobsen Erik H; Price Karen N; Goldhirsch Aron
Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(5):486-92.
2007: Moghrabi Albert; Levy Donna E; Asselin Barbara; Barr Ronald; Clavell Luis; Hurwitz Craig; Samson Yvan; Schorin Marshall; Dalton Virginia K; Lipshultz Steven E; Neuberg Donna S; Gelber Richard D; Cohen Harvey J; Sallan Stephen E; Silverman Lewis B
Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia.
Blood 2007;109(3):896-904.
2007: Smith Ian; Procter Marion; Gelber Richard D; Guillaume Sébastien; Feyereislova Andrea; Dowsett Mitch; Goldhirsch Aron; Untch Michael; Mariani Gabriella; Baselga Jose; Kaufmann Manfred; Cameron David; Bell Richard; Bergh Jonas; Coleman Robert; Wardley Andrew; Harbeck Nadia; Lopez Roberto I; Mallmann Peter; Gelmon Karen; Wilcken Nicholas; Wist Erik; Sánchez Rovira Pedro; Piccart-Gebhart Martine J;
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial.
Lancet 2007;369(9555):29-36.
2007: Bernhard Jürg; Zahrieh David; Castiglione-Gertsch Monica; Hürny Christoph; Gelber Richard D; Forbes John F; Murray Elizabeth; Collins John; Aebi Stefan; Thürlimann Beat; Price Karen N; Goldhirsch Aron; Coates Alan S;
Adjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):263-70.
2006: Goldhirsch A; Coates A S; Gelber R D; Glick J H; Thürlimann B; Senn H-J;
First--select the target: better choice of adjuvant treatments for breast cancer patients.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(12):1772-6.
2006: Regan Meredith M; Viale Giuseppe; Mastropasqua Mauro G; Maiorano Eugenio; Golouh Rastko; Carbone Antonino; Brown Bob; Suurküla Mart; Langman Gerald; Mazzucchelli Luca; Braye Stephen; Grigolato Piergiovanni; Gelber Richard D; Castiglione-Gertsch Monica; Price Karen N; Coates Alan S; Goldhirsch Aron; Gusterson Barry;
Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Journal of the National Cancer Institute 2006;98(21):1571-81.
2006: Pestalozzi B C; Zahrieh D; Price K N; Holmberg S B; Lindtner J; Collins J; Crivellari D; Fey M F; Murray E; Pagani O; Simoncini E; Castiglione-Gertsch M; Gelber R D; Coates A S; Goldhirsch A;
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(6):935-44.
2006: Colleoni Marco; Gelber Shari; Goldhirsch Aron; Aebi Stefan; Castiglione-Gertsch Monica; Price Karen N; Coates Alan S; Gelber Richard D
Tamoxifen after adjuvant chemotherapy for premenopausal women with lymph node-positive breast cancer: International Breast Cancer Study Group Trial 13-93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1332-41.
2006: Gianni Lorenzo; Panzini Ilaria; Li Sigui; Gelber Richard D; Collins John; Holmberg Stig B; Crivellari Diana; Castiglione-Gertsch Monica; Goldhirsch Aron; Coates Alan S; Ravaioli Alberto;
Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Cancer 2006;106(3):505-13.
2006: Basser Russell L; O'Neill Anne; Martinelli Giovanni; Green Michael D; Peccatori Fedro; Cinieri Saverio; Coates Alan S; Gelber Richard D; Aebi Stefan; Castiglione-Gertsch Monica; Viale Guiseppe; Price Karen N; Goldhirsch Aron
Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):370-8.
2006: Rudenstam Carl-Magnus; Zahrieh David; Forbes John F; Crivellari Diana; Holmberg Stig B; Rey Piercarlo; Dent David; Campbell Ian; Bernhard Jürg; Price Karen N; Castiglione-Gertsch Monica; Goldhirsch Aron; Gelber Richard D; Coates Alan S
Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):337-44.
2005: Thürlimann Beat; Keshaviah Aparna; Coates Alan S; Mouridsen Henning; Mauriac Louis; Forbes John F; Paridaens Robert; Castiglione-Gertsch Monica; Gelber Richard D; Rabaglio Manuela; Smith Ian; Wardley Andrew; Price Karen N; Goldhirsch Aron
A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
The New England journal of medicine 2005;353(26):2747-57.
2005: Regan Meredith M; Gelber Richard D
Predicting response to systemic treatments: learning from the past to plan for the future.
Breast (Edinburgh, Scotland) 2005;14(6):582-93.
2005: Piccart-Gebhart Martine J; Procter Marion; Leyland-Jones Brian; Goldhirsch Aron; Untch Michael; Smith Ian; Gianni Luca; Baselga Jose; Bell Richard; Jackisch Christian; Cameron David; Dowsett Mitch; Barrios Carlos H; Steger Günther; Huang Chiun-Shen; Andersson Michael; Inbar Moshe; Lichinitser Mikhail; Láng István; Nitz Ulrike; Iwata Hiroji; Thomssen Christoph; Lohrisch Caroline; Suter Thomas M; Rüschoff Josef; Suto Tamás; Greatorex Victoria; Ward Carol; Straehle Carolyn; McFadden Eleanor; Dolci M Stella; Gelber Richard D;
Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.
The New England journal of medicine 2005;353(16):1659-72.
2005: Gruber Günther; Bonetti Marco; Nasi M Laura; Price Karen N; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Holmberg Stig B; Lindtner Jurij; Golouh Rastko; Collins John; Crivellari Diana; Carbone Antonino; Thürlimann Beat; Simoncini Edda; Fey Martin F; Gelber Richard D; Coates Alan S; Goldhirsch Aron;
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):7089-97.
2005: Goldhirsch A; Glick J H; Gelber R D; Coates A S; Thürlimann B; Senn H-J;
Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(10):1569-83.
2005: Goldhirsch Aron; Gelber Richard D; Coates Alan S
What are the long-term effects of chemotherapy and hormonal therapy for early breast cancer?
Nature clinical practice. Oncology 2005;2(9):440-1.
2005: Colleoni Marco; Li Sigui; Gelber Richard D; Price Karen N; Coates Alan S; Castiglione-Gertsch Monica; Goldhirsch Aron;
Relation between chemotherapy dose, oestrogen receptor expression, and body-mass index.
Lancet 2005;366(9491):1108-10.
2005: Cole Bernard F; Bonetti Marco; Zaslavsky Alan M; Gelber Richard D
A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.
Statistics in medicine 2005;24(15):2317-34.
2005: Goldhirsch Aron; Gelber Richard D; Viale Giuseppe; Colleoni Marco; Coates Alan S
Prediction of cancer outcome with microarrays.
Lancet 2005;365(9472):1685-6; author reply 1686.
2005: Colleoni M; Li S; Gelber R D; Coates A S; Castiglione-Gertsch M; Price K N; Lindtner J; Rudenstam C-M; Crivellari D; Collins J; Pagani O; Simoncini E; Thürlimann B; Murray E; Forbes J; Erzen D; Holmberg S; Veronesi A; Goldhirsch A
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(5):716-25.
2005: Lipshultz Steven E; Lipsitz Stuart R; Sallan Stephen E; Dalton Virginia M; Mone Suzanne M; Gelber Richard D; Colan Steven D
Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2629-36.
2005: Dellapasqua Silvia; Colleoni Marco; Gelber Richard D; Goldhirsch Aron
Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(8):1736-50.
2005: Colleoni Marco; Zahrieh David; Gelber Richard D; Holmberg Stig B; Mattsson Jan E; Rudenstam Carl-Magnus; Lindtner Jurij; Erzen Darja; Snyder Raymond; Collins John; Fey Martin F; Thürlimann Beat; Crivellari Diana; Murray Elizabeth; Mendiola Caesar; Pagani Olivia; Castiglione-Gertsch Monica; Coates Alan S; Price Karen; Goldhirsch Aron
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1390-400.
2005: Winer Eric P; Hudis Clifford; Burstein Harold J; Wolff Antonio C; Pritchard Kathleen I; Ingle James N; Chlebowski Rowan T; Gelber Richard; Edge Stephan B; Gralow Julie; Cobleigh Melody A; Mamounas Eleftherios P; Goldstein Lori J; Whelan Timothy J; Powles Trevor J; Bryant John; Perkins Cheryl; Perotti Judy; Braun Susan; Langer Amy S; Browman George P; Somerfield Mark R
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):619-29.
2004: Goldhirsch Aron; Gelber Richard D
Life with consequences of breast cancer: pregnancy during and after endocrine therapies.
Breast (Edinburgh, Scotland) 2004;13(6):443-5.
2004: Pagani Olivia; Gelber Shari; Price Karen; Zahrieh David; Gelber Richard; Simoncini Edda; Castiglione-Gertsch Monica; Coates Alan S; Goldhirsch Aron
Toremifene and tamoxifen are equally effective for early-stage breast cancer: first results of International Breast Cancer Study Group Trials 12-93 and 14-93.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(12):1749-59.
2004: Bernhard J; Zahrieh D; Coates A S; Gelber R D; Castiglione-Gertsch M; Murray E; Forbes J F; Perey L; Collins J; Snyder R; Rudenstam C-M; Crivellari D; Veronesi A; Thürlimann B; Fey M F; Price K N; Goldhirsch A; Hürny C
Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer.
British journal of cancer 2004;91(11):1893-901.
2004: Colleoni Marco; Viale Giuseppe; Zahrieh David; Pruneri Giancarlo; Gentilini Oreste; Veronesi Paolo; Gelber Richard D; Curigliano Giuseppe; Torrisi Rosalba; Luini Alberto; Intra Mattia; Galimberti Viviana; Renne Giuseppe; Nolè Franco; Peruzzotti Giulia; Goldhirsch Aron
Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6622-8.
2004: Lipshultz Steven E; Rifai Nader; Dalton Virginia M; Levy Donna E; Silverman Lewis B; Lipsitz Stuart R; Colan Steven D; Asselin Barbara L; Barr Ronald D; Clavell Luis A; Hurwitz Craig A; Moghrabi Albert; Samson Yvan; Schorin Marshall A; Gelber Richard D; Sallan Stephen E
The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia.
The New England journal of medicine 2004;351(2):145-53.
2004: Waber Deborah P; Silverman Lewis B; Catania Lori; Mautz William; Rue Montse; Gelber Richard D; Levy Donna E; Goldwasser Meredith A; Adams Heather; Dufresne Annie; Metzger Victoria; Romero Ivonne; Tarbell Nancy J; Dalton Virginia Kimball; Sallan Stephen E
Outcomes of a randomized trial of hyperfractionated cranial radiation therapy for treatment of high-risk acute lymphoblastic leukemia: therapeutic efficacy and neurotoxicity.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2701-7.
2004: Bonetti Marco; Gelber Richard D
Patterns of treatment effects in subsets of patients in clinical trials.
Biostatistics (Oxford, England) 2004;5(3):465-81.
2004: Berclaz G; Li S; Price K N; Coates A S; Castiglione-Gertsch M; Rudenstam C-M; Holmberg S B; Lindtner J; Erien D; Collins J; Snyder R; Thürlimann B; Fey M F; Mendiola C; Werner I Dudley; Simoncini E; Crivellari D; Gelber R D; Goldhirsch A;
Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(6):875-84.
2004: Cole Bernard F; Gelber Richard D; Gelber Shari; Mukhopadhyay Pabak
A quality-adjusted survival (Q-TWiST) model for evaluating treatments for advanced stage cancer.
Journal of biopharmaceutical statistics 2004;14(1):111-24.
2004: Colleoni M; Rotmensz N; Martinelli G; Gelber R; Coates A; Goldhirsch A
Lesson learned from high-dose chemotherapy for high-risk breast cancer (What you see is what you mean).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(2):355-6.
2003: Castiglione-Gertsch Monica; O'Neill Anne; Price Karen N; Goldhirsch Aron; Coates Alan S; Colleoni Marco; Nasi M Laura; Bonetti Marco; Gelber Richard D
Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial.
Journal of the National Cancer Institute 2003;95(24):1833-46.
2003: Crivellari Diana; Price Karen; Gelber Richard D; Castiglione-Gertsch Monica; Rudenstam Carl-Magnus; Lindtner Jurij; Fey Martin F; Senn Hans-Jörg; Coates Alan S; Collins John; Goldhirsch Aron;
Adjuvant endocrine therapy compared with no systemic therapy for elderly women with early breast cancer: 21-year results of International Breast Cancer Study Group Trial IV.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(24):4517-23.
2003: Senn H-J; Thürlimann B; Goldhirsch A; Wood W C; Gelber R D; Coates A S
Comments on the St. Gallen Consensus 2003 on the Primary Therapy of Early Breast Cancer.
Breast (Edinburgh, Scotland) 2003;12(6):569-82.
2003: Gelber R D; Bonetti M; Castiglione-Gertsch M; Coates A S; Goldhirsch A;
Tailoring adjuvant treatments for the individual breast cancer patient.
Breast (Edinburgh, Scotland) 2003;12(6):558-68.
2003: Colleoni M; Zahrieh D; Gelber R D; Viale G; Luini A; Veronesi P; Intra M; Galimberti V; Renne G; Goldhirsch A;
Preoperative systemic treatment: prediction of responsiveness.
Breast (Edinburgh, Scotland) 2003;12(6):538-42.
2003: Goldberg John M; Silverman Lewis B; Levy Donna E; Dalton Virginia Kimball; Gelber Richard D; Lehmann Leslie; Cohen Harvey J; Sallan Stephen E; Asselin Barbara L
Childhood T-cell acute lymphoblastic leukemia: the Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3616-22.
2003: Goldhirsch Aron; Wood William C; Gelber Richard D; Coates Alan S; Thürlimann Beat; Senn Hans-Jörg
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(17):3357-65.
2003: Dalton Virginia Kimball; Rue Montse; Silverman Lewis B; Gelber Richard D; Asselin Barbara L; Barr Ronald D; Clavell Luis A; Hurwitz Craig A; Moghrabi Albert; Samson Yvan; Schorin Marshall; Tarbell Nancy J; Sallan Stephen E; Cohen Laurie E
Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2953-60.
2003: Goldhirsch A; Colleoni M; Domenighetti G; Gelber R D
Systemic treatments for women with breast cancer: outcome with relation to screening for the disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1212-4.
2003: Wallgren A; Bonetti M; Gelber R D; Goldhirsch A; Castiglione-Gertsch M; Holmberg S B; Lindtner J; Thürlimann B; Fey M; Werner I D; Forbes J F; Price K; Coates A S; Collins J;
Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1205-13.
2003: Spataro Vito J; Litman Heather; Viale Giuseppe; Maffini Fausto; Masullo Michele; Golouh Rastko; Martinez-Tello Francisco J; Grigolato Piergioranni; Shilkin Keith B; Gusterson Barry A; Castiglione-Gertsch Monica; Price Karen; Lindtner Jurii; Cortés-Funes Hernan; Simoncini Edda; Byrne Michael J; Collins John; Gelber Richard D; Coates Alan S; Goldhirsch Aron;
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
Cancer 2003;97(7):1591-600.
2003: Trihia Helen; Murray Susan; Price Karen; Gelber Richard D; Golouh Rastko; Goldhirsch Aron; Coates Alan S; Collins John; Castiglione-Gertsch Monica; Gusterson Barry A;
Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors--a surrogate marker?
Cancer 2003;97(5):1321-31.
2002: Lipshultz Steven E; Lipsitz Stuart R; Sallan Stephen E; Simbre Valeriano C; Shaikh Seema L; Mone Suzanne M; Gelber Richard D; Colan Steven D
Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4517-22.
2002: Coates Alan; Goldhirsch Aron; Gelber Richard;
Overhauling the breast cancer overview: are subsets subversive?
The lancet oncology 2002;3(9):525-6.
2002: Colleoni M; Litman H J; Castiglione-Gertsch M; Sauerbrei W; Gelber R D; Bonetti M; Coates A S; Schumacher M; Bastert G; Rudenstam C-M; Schmoor C; Lindtner J; Collins J; Thürlimann B; Holmberg S B; Crivellari D; Beyerle C; Neumann R L A; Goldhirsch A;
Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF.
British journal of cancer 2002;86(11):1705-14.
2002: Earle Craig C; Neumann Peter J; Gelber Richard D; Weinstein Milton C; Weeks Jane C
Impact of referral patterns on the use of chemotherapy for lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(7):1786-92.
2002: Lipshultz Steven E; Giantris Amy L; Lipsitz Stuart R; Kimball Dalton Virginia; Asselin Barbara L; Barr Ronald D; Clavell Luis A; Hurwitz Craig A; Moghrabi Albert; Samson Yvan; Schorin Marshall A; Gelber Richard D; Sallan Stephen E; Colan Steven D
Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1677-82.
2002: LeClerc Jean Marie; Billett Amy L; Gelber Richard D; Dalton Virginia; Tarbell Nancy; Lipton Jeffrey M; Barr Ronald; Clavell Luis A; Asselin Barbara; Hurwitz Craig; Schorin Marshall; Lipshultz Steven E; Declerck Lieven; Silverman Lewis B; Cohen Harvey J; Sallan Stephen E
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber ALL Consortium Protocol 87-01.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(1):237-46.
2002: Goldhirsch A; Colleoni M; Gelber R D
Endocrine therapy of breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13 Suppl 4():61-8.
2001: Colleoni M; Gelber S; Coates A S; Castiglione-Gertsch M; Gelber R D; Price K; Rudenstam C M; Lindtner J; Collins J; Thürlimann B; Holmberg S B; Cortes-Funes H; Simoncini E; Murray E; Fey M; Goldhirsch A;
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(21):4141-9.
2001: Goldhirsch A; Glick J H; Gelber R D; Coates A S; Senn H J
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(18):3817-27.
2001: Cole B F; Gelber R D; Gelber S; Coates A S; Goldhirsch A
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysis.
Lancet 2001;358(9278):277-86.
2001: Waber D P; Shapiro B L; Carpentieri S C; Gelber R D; Zou G; Dufresne A; Romero I; Tarbell N J; Silverman L B; Sallan S E
Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01.
Cancer 2001;92(1):15-22.
2001: Strauss A J; Su J T; Dalton V M; Gelber R D; Sallan S E; Silverman L B
Bony morbidity in children treated for acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(12):3066-72.
2001: Gelber S; Coates A S; Goldhirsch A; Castiglione-Gertsch M; Marini G; Lindtner J; Edelmann D Z; Gudgeon A; Harvey V; Gelber R D;
Effect of pregnancy on overall survival after the diagnosis of early-stage breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1671-5.
2001: Silverman L B; Gelber R D; Dalton V K; Asselin B L; Barr R D; Clavell L A; Hurwitz C A; Moghrabi A; Samson Y; Schorin M A; Arkin S; Declerck L; Cohen H J; Sallan S E
Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.
Blood 2001;97(5):1211-8.
2001: Earle C C; Tsai J S; Gelber R D; Weinstein M C; Neumann P J; Weeks J C
Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1064-70.
2001: Schwartz C L; Thompson E B; Gelber R D; Young M L; Chilton D; Cohen H J; Sallan S E
Improved response with higher corticosteroid dose in children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1040-6.
2001: Kitchen P R; Smith T H; Henderson M A; Goldhirsch A; Castiglione-Gertsch M; Coates A S; Gusterson B; Brown R W; Gelber R D; Collins J P
Tubular carcinoma of the breast: prognosis and response to adjuvant systemic therapy.
ANZ journal of surgery 2001;71(1):27-31.
2001: Goldhirsch A; Gelber R D; Yothers G; Gray R J; Green S; Bryant J; Gelber S; Castiglione-Gertsch M; Coates A S
Adjuvant therapy for very young women with breast cancer: need for tailored treatments.
Journal of the National Cancer Institute. Monographs 2001;(30):44-51.
2000: Silverman L B; Declerck L; Gelber R D; Dalton V K; Asselin B L; Barr R D; Clavell L A; Hurwitz C A; Moghrabi A; Samson Y; Schorin M A; Lipton J M; Cohen H J; Sallan S E
Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2247-56.
2000: Colleoni M; O'Neill A; Goldhirsch A; Gelber R D; Bonetti M; Thürlimann B; Price K N; Castiglione-Gertsch M; Coates A S; Lindtner J; Collins J; Senn H J; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Rudenstam C M
Identifying breast cancer patients at high risk for bone metastases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(23):3925-35.
2000: Coates A S; Hürny C; Peterson H F; Bernhard J; Castiglione-Gertsch M; Gelber R D; Goldhirsch A
Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3768-74.
2000: Bonetti M; Gelber R D
A graphical method to assess treatment-covariate interactions using the Cox model on subsets of the data.
Statistics in medicine 2000;19(19):2595-609.
2000: Goldhirsch A; Francis P; Castiglione-Gertsch M; Gelber R D; Coates A S
Taxanes as adjuvant for breast cancer.
Lancet 2000;356(9228):507-8.
2000: Aebi S; Gelber S; Castiglione-Gertsch M; Gelber R D; Collins J; Thürlimann B; Rudenstam C M; Lindtner J; Crivellari D; Cortes-Funes H; Simoncini E; Werner I D; Coates A S; Goldhirsch A
Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer?
Lancet 2000;355(9218):1869-74.
2000: Earle C C; Venditti L N; Neumann P J; Gelber R D; Weinstein M C; Potosky A L; Weeks J C
Who gets chemotherapy for metastatic lung cancer?
Chest 2000;117(5):1239-46.
2000: Hurwitz C A; Silverman L B; Schorin M A; Clavell L A; Dalton V K; Glick K M; Gelber R D; Sallan S E
Substituting dexamethasone for prednisone complicates remission induction in children with acute lymphoblastic leukemia.
Cancer 2000;88(8):1964-9.
2000: Crivellari D; Bonetti M; Castiglione-Gertsch M; Gelber R D; Rudenstam C M; Thürlimann B; Price K N; Coates A S; Hürny C; Bernhard J; Lindtner J; Collins J; Senn H J; Cavalli F; Forbes J; Gudgeon A; Simoncini E; Cortes-Funes H; Veronesi A; Fey M; Goldhirsch A
Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the International Breast Cancer Study Group Trial VII.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1412-22.
2000: Castiglione-Gertsch M; Gelber R D; O'Neill A; Coates A S; Goldhirsch A
Systemic adjuvant treatment for premenopausal node-negative breast cancer. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 2000;36(4):549-50.
2000: Colleoni M; Bonetti M; Coates A S; Castiglione-Gertsch M; Gelber R D; Price K; Rudenstam C M; Lindtner J; Collins J; Thürlimann B; Holmberg S; Veronesi A; Marini G; Goldhirsch A
Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(3):584-90.
1999: Cote R J; Peterson H F; Chaiwun B; Gelber R D; Goldhirsch A; Castiglione-Gertsch M; Gusterson B; Neville A M
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group.
Lancet 1999;354(9182):896-900.
1999: Parsons S K; Gelber S; Cole B F; Ravindranath Y; Ogden A; Yeager A M; Chang M; Shuster J; Weinstein H J; Gelber R D
Quality-adjusted survival after treatment for acute myeloid leukemia in childhood: A Q-TWiST analysis of the Pediatric Oncology Group Study 8821.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2144-52.
1999: Colleoni M; Price K N; Castiglione-Gertsch M; Gelber R D; Coates A S; Goldhirsch A
Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil. International Breast Cancer Study Group.
Lancet 1999;354(9173):130-1.
1999: Silverman L B; Gelber R D; Young M L; Dalton V K; Barr R D; Sallan S E
Induction failure in acute lymphoblastic leukemia of childhood.
Cancer 1999;85(6):1395-404.
1999: Asselin B L; Kreissman S; Coppola D J; Bernal S D; Leavitt P R; Gelber R D; Sallan S E; Cohen H J
Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(1):6-12.
1998: Coates A S; Gelber R D; Goldhirsch A
Subsets within the chemotherapy overview. International Breast Cancer Study Group.
Lancet 1998;352(9142):1783-4.
1998: Goldhirsch A; Glick J H; Gelber R D; Senn H J
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
Journal of the National Cancer Institute 1998;90(21):1601-8.
1998: Colleoni M; Price K; Castiglione-Gertsch M; Goldhirsch A; Coates A; Lindtner J; Collins J; Gelber R D; Thürlimann B; Rudenstam C M
Dose-response effect of adjuvant cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in node-positive breast cancer. International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1998;34(11):1693-700.
1998: Pinder S E; Murray S; Ellis I O; Trihia H; Elston C W; Gelber R D; Goldhirsch A; Lindtner J; Cortés-Funes H; Simoncini E; Byrne M J; Golouh R; Rudenstam C M; Castiglione-Gertsch M; Gusterson B A
The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
Cancer 1998;83(8):1529-39.
1998: Goldhirsch A; Coates A S; Castiglione-Gertsch M; Gelber R D
New treatments for breast cancer: breakthroughs for patient care or just steps in the right direction?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(9):973-6.
1998: Bernhard J; Hürny C; Coates A S; Peterson H F; Castiglione-Gertsch M; Gelber R D; Galligioni E; Marini G; Thürlimann B; Forbes J F; Goldhirsch A; Senn H J; Rudenstam C M
Factors affecting baseline quality of life in two international adjuvant breast cancer trials. International Breast Cancer Study Group (IBCSG).
British journal of cancer 1998;78(5):686-93.
1998: Kimball Dalton V M; Gelber R D; Li F; Donnelly M J; Tarbell N J; Sallan S E
Second malignancies in patients treated for childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2848-53.
1998: Cole B F; Solal-Céligny P; Gelber R D; Lepage E; Gisselbrecht C; Reyes F; Sebban C; Sugano D; Tendler C; Goldhirsch A
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision making.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(7):2339-44.
1998: Goldhirsch A; Colleoni M; Coates A S; Castiglione-Gertsch M; Gelber R D
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(5):489-93.
1998: Pagani O; O'Neill A; Castiglione M; Gelber R D; Goldhirsch A; Rudenstam C M; Lindtner J; Collins J; Crivellari D; Coates A; Cavalli F; Thürlimann B; Simoncini E; Fey M; Price K; Senn H J
Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
European journal of cancer (Oxford, England : 1990) 1998;34(5):632-40.
1998: Goldhirsch A; Coates A S; Colleoni M; Castiglione-Gertsch M; Gelber R D
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1358-62.
1998: Bernhard J; Peterson H F; Coates A S; Gusset H; Isley M; Hinkle R; Gelber R D; Castiglione-Gertsch M; Hürny C
Quality of life assessment in International Breast Cancer Study Group (IBCSG) trials: practical issues and factors associated with missing data.
Statistics in medicine 1998;17(5-7):587-601.
1998: Goldhirsch A; Coates A S; Colleoni M; Gelber R D
Radiotherapy and chemotherapy in high-risk breast cancer.
The New England journal of medicine 1998;338(5):330-1; author reply 331-2.
1998: Goldhirsch A; Glick J H; Gelber R D; Senn H J
International Consensus Panel on the treatment of primary breast cancer. V: Update 1998.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():481-97.
1998: Gelber R D; Bonetti M; Cole B F; Gelber S; Goldhirsch A
Quality of life assessment in the adjuvant setting: is it relevant? International Breast Cancer Study Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():373-89.
1997: Castiglione-Gertsch M; Tattersall M; Hacking A; Goldhirsch A; Gudgeon A; Gelber R D; Lindtner J; Coates A; Collins J; Isley M; Senn H J; Rudenstam C M
Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1997;33(14):2321-5.
1997: Silverman L B; McLean T W; Gelber R D; Donnelly M J; Gilliland D G; Tarbell N J; Sallan S E
Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium.
Cancer 1997;80(12):2285-95.
1997: Bernhard J; Hürny C; Coates A S; Peterson H F; Castiglione-Gertsch M; Gelber R D; Goldhirsch A; Senn H J; Rudenstam C M
Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(9):825-35.
1997: Goldhirsch A; Gelber R D; Castiglione M; O'Neill A; Thürlimann B; Rudenstam C M; Lindtner J; Collins J; Forbes J; Crivellari D; Coates A; Cavalli F; Simoncini E; Fey M F; Pagani O; Price K; Senn H J
Menstrual cycle and timing of breast surgery in premenopausal node-positive breast cancer: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(8):751-6.
1997: Pestalozzi B C; Peterson H F; Gelber R D; Goldhirsch A; Gusterson B A; Trihia H; Lindtner J; Cortés-Funes H; Simmoncini E; Byrne M J; Golouh R; Rudenstam C M; Castiglione-Gertsch M; Allegra C J; Johnston P G
Prognostic importance of thymidylate synthase expression in early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1923-31.
1996: Cole B F; Gelber R D; Kirkwood J M; Goldhirsch A; Barylak E; Borden E
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2666-73.
1996: Goldhirsch A; Gelber R D
Endocrine therapies of breast cancer.
Seminars in oncology 1996;23(4):494-505.
1996: Gelber R D; Goldhirsch A; Cole B F; Wieand H S; Schroeder G; Krook J E
A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer.
Journal of the National Cancer Institute 1996;88(15):1039-45.
1996: Wallgren A; Bernier J; Gelber R D; Goldhirsch A; Roncadin M; Joseph D; Castiglione-Gertsch M
Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
International journal of radiation oncology, biology, physics 1996;35(4):649-59.
1996: Hürny C; Bernhard J; Coates A S; Castiglione-Gertsch M; Peterson H F; Gelber R D; Forbes J F; Rudenstam C M; Simoncini E; Crivellari D; Goldhirsch A; Senn H J
Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group.
Lancet 1996;347(9011):1279-84.
1996: Gelber R D
Gemcitabine for pancreatic cancer: how hard to look for clinical benefit? An American perspective.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(4):335-7.
1996: Gelber R D; Cole B F; Goldhirsch A; Rose C; Fisher B; Osborne C K; Boccardo F; Gray R; Gordon N H; Bengtsson N O; Sevelda P
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival.
Lancet 1996;347(9008):1066-71.
1996: Marini G; Murray S; Goldhirsch A; Gelber R D; Castiglione-Gertsch M; Price K N; Tattersall M H; Rudenstam C M; Collins J; Lindtner J; Cavalli F; Cortés-Funes H; Gudgeon A; Forbes J F; Galligioni E; Coates A S; Senn H J
The effect of adjuvant prednisone combined with CMF on patterns of relapse and occurrence of second malignancies in patients with breast cancer. International (Ludwig) Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(3):245-50.
1996: Hürny C; Bernhard J; Coates A; Peterson H F; Castiglione-Gertsch M; Gelber R D; Rudenstam C M; Collins J; Lindtner J; Goldhirsch A; Senn H J
Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.
Medical care 1996;34(3):234-48.
1996: Goldhirsch A; Wood W C; Senn H J; Glick J H; Gelber R D
IX. International consensus conference on primary treatment of breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():325-35.
1996: Castiglione-Gertsch M; Gelber R D; Goldhirsch A
Adjuvant systemic therapy: the issues of timing and sequence.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():201-13.
1995: Crivellari D; Price K N; Hagen M; Goldhirsch A; Gelber R D; Castiglione M; Coates A S; Rudenstam C M; Collins J; Lindtner J
Routine tests during follow-up of patients after primary treatment for operable breast cancer. International (Ludwig) Breast Cancer Study Group (IBCSG)
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(8):769-76.
1995: Goldhirsch A; Wood W C; Senn H J; Glick J H; Gelber R D
Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(11):1754-9.
1995: Goldhirsch A; Wood W C; Senn H J; Glick J H; Gelber R D
Meeting highlights: international consensus panel on the treatment of primary breast cancer.
Journal of the National Cancer Institute 1995;87(19):1441-5.
1995: Schwartz C E; Cole B F; Gelber R D
Measuring patient-centered outcomes in neurologic disease. Extending the Q-TWiST method.
Archives of neurology 1995;52(8):754-62.
1995: Cole B F; Gelber R D; Goldhirsch A
A quality-adjusted survival meta-analysis of adjuvant chemotherapy for premenopausal breast cancer. International Breast Cancer Study Group.
Statistics in medicine 1995;14(16):1771-84.
1995: Gelber R D; Cole B F; Goldhirsch A; Bonadonna G; Howell A; McArdle C S; Mouridsen H T; Rubens R D; Welvaart K
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival.
The cancer journal from Scientific American 1995;1(2):114-21.
1995: Lipshultz S E; Lipsitz S R; Mone S M; Goorin A M; Sallan S E; Sanders S P; Orav E J; Gelber R D; Colan S D
Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
The New England journal of medicine 1995;332(26):1738-43.
1995: Schwartz C E; Cole B F; Vickrey B G; Gelber R D
The Q-TWiST approach to assessing health-related quality of life in epilepsy.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 1995;4(2):135-41.
1995: Hürny C; Bernhard J; Coates A; Peterson H F; Gelber R D
The quality of quality-of-life measurements.
JAMA : the journal of the American Medical Association 1995;273(11):843; author reply 844-5.
1995: Goldhirsch A; Gelber R D; Castiglione M; Price K N; Rudenstam C M; Lindtner J; Collins J; Senn H J; Cavalli F; Galligioni E
The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.
Israel journal of medical sciences 1995;31(2-3):144-54.
1995: Gelber R D; Gelber S
Quality-of-life assessment in clinical trials.
Cancer treatment and research 1995;75():225-46.
1994: Castiglione-Gertsch M; Johnsen C; Goldhirsch A; Gelber R D; Rudenstam C M; Collins J; Lindtner J; Hacking A; Cortes-Funes H; Forbes J
The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):717-24.
1994: Cole B F; Gelber R D; Anderson K M
Parametric approaches to quality-adjusted survival analysis. International Breast Cancer Study Group.
Biometrics 1994;50(3):621-31.
1994: Goldhirsch A; Gelber R D; Castiglione M; Price K N; Rudenstam C M; Lindtner J; Collins J; Senn H J; Brunner K W; Galligioni E
Present and future projects of the International Breast Cancer Study Group.
Cancer 1994;74(3 Suppl):1139-49.
1994: Gelber R D; Goldhirsch A
Radiotherapy to the conserved breast: is it avoidable if the cancer is small?
Journal of the National Cancer Institute 1994;86(9):652-4.
1994: Goldhirsch A; Gelber R D
Understanding adjuvant chemotherapy for breast cancer.
The New England journal of medicine 1994;330(18):1308-9.
1994: Schorin M A; Blattner S; Gelber R D; Tarbell N J; Donnelly M; Dalton V; Cohen H J; Sallan S E
Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):740-7.
1994: Goldhirsch A; Gelber R D; Castiglione M
Testing tumor dormancy in breast cancer.
Journal of the National Cancer Institute 1994;86(7):558.
1994: Lenderking W R; Gelber R D; Cotton D J; Cole B F; Goldhirsch A; Volberding P A; Testa M A
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.
The New England journal of medicine 1994;330(11):738-43.
1994: Goldhirsch A; Gelber R D; Price K N; Castiglione M; Coates A S; Rudenstam C M; Collins J; Lindtner J; Hacking A; Marini G
Effect of systemic adjuvant treatment on first sites of breast cancer relapse.
Lancet 1994;343(8894):377-81.
1994: Hürny C; Bernhard J; Coates A; Castiglione M; Peterson H F; Gelber R D; Rudenstam C M; Goldhirsch A; Senn H J
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(1):65-74.
1993: Gelber R D; Goldhirsch A; Cole B F
Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International Breast Cancer Study Group.
Controlled clinical trials 1993;14(6):485-99.
1993: Gelber R D; Sallan S E; Cohen H J; Donnelly M; Dalton V; Tobia F; Clavell L A; Tarbell N J
Central nervous system treatment in childhood acute lymphoblastic leukemia. Long-term follow-up of patients diagnosed between 1973 and 1985.
Cancer 1993;72(1):261-70.
1993: Gelber R D; Goldhirsch A; Castiglione M; Rudenstram C M; Collins J; Senn H J
Premenopausal oopherectomy versus CMF chemotherapy in stage II breast carcinoma. The International Breast Cancer Study Group (IBCSG)
Lancet 1993;342(8866):305.
1993: Tarbell N J; Gelber R D; Weinstein H J; Mauch P
Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood.
Lancet 1993;341(8858):1428-32.
1993: Cole B F; Gelber R D; Goldhirsch A
Cox regression models for quality adjusted survival analysis.
Statistics in medicine 1993;12(10):975-87.
1993: Zerbini C; Gelber R D; Weinberg D; Sallan S E; Barnes P; Kupsky W; Scott R M; Tarbell N J
Prognostic factors in medulloblastoma, including DNA ploidy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):616-22.
1993: Billett A L; Kornmehl E; Tarbell N J; Weinstein H J; Gelber R D; Ritz J; Sallan S E
Autologous bone marrow transplantation after a long first remission for children with recurrent acute lymphoblastic leukemia.
Blood 1993;81(6):1651-7.
1993: Gelber R D; Goldhirsch A; Coates A S
Adjuvant therapy for breast cancer: understanding the overview. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(3):580-5.
1993: Glick J H; Gelber R D; Goldhirsch A; Senn H J
Adjuvant therapy of primary breast cancer: closing summary.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():289-300.
1993: Gelber R D; Cole B F; Goldhirsch A
How to compare quality of life of breast cancer patients in clinical trials. International Breast Cancer Study Group.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():221-33.
1993: Gelber R D; Goldhirsch A
From the overview to the patient: how to interpret meta-analysis data.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():167-76.
1993: Gelber R D; Goldhirsch A; Cole B F
Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group.
Cancer treatment reviews 1993;19 Suppl A():73-84.
1992: Glick J H; Gelber R D; Goldhirsch A; Senn H J
Adjuvant therapy of primary breast cancer. 4th International Conference on Adjuvant Therapy of Primary Breast Cancer St. Gallen, Switzerland.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):801-7.
1992: Spataro V; Price K; Goldhirsch A; Cavalli F; Simoncini E; Castiglione M; Rudenstam C M; Collins J; Lindtner J; Gelber R D
Sequential estrogen receptor determinations from primary breast cancer and at relapse: prognostic and therapeutic relevance. The International Breast Cancer Study Group (formerly Ludwig Group).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):733-40.
1992: Gelber R D; Coates A S; Goldhirsch A
Meta-analysis: the fashion of summing-up evidence. Part II: Interpretations and uses.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(9):683-91.
1992: Glick J H; Gelber R D; Goldhirsch A; Senn H J
Meeting highlights: adjuvant therapy for primary breast cancer.
Journal of the National Cancer Institute 1992;84(19):1479-85.
1992: Kreissman S G; Gelber R D; Cohen H J; Clavell L A; Leavitt P; Sallan S E
Incidence of secondary acute myelogenous leukemia after treatment of childhood acute lymphoblastic leukemia.
Cancer 1992;70(8):2208-13.
1992: Billett A L; Carls A; Gelber R D; Sallan S E
Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukemia who had previous allergic reactions to Escherichia coli asparaginase.
Cancer 1992;70(1):201-6.
1992: Gusterson B A; Gelber R D; Goldhirsch A; Price K N; Säve-Söderborgh J; Anbazhagan R; Styles J; Rudenstam C M; Golouh R; Reed R
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(7):1049-56.
1992: Gelber R D; Lenderking W R; Cotton D J; Cole B F; Fischl M A; Goldhirsch A; Testa M A
Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group.
Annals of internal medicine 1992;116(12 Pt 1):961-6.
1992: Waber D P; Tarbell N J; Kahn C M; Gelber R D; Sallan S E
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):810-7.
1992: Neville A M; Bettelheim R; Gelber R D; Säve-Söderbergh J; Davis B W; Reed R; Torhorst J; Golouh R; Peterson H F; Price K N
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(5):696-705.
1992: Gelber R D; Coates A S; Goldhirsch A
Adjuvant treatment for breast cancer: the overview.
BMJ (Clinical research ed.) 1992;304(6831):859-60.
1992: Drigan R; Spirito A; Gelber R D
Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.
Medical and pediatric oncology 1992;20(1):13-21.
1992: Goldhirsch A; Castiglione M; Gelber R D
A single perioperative adjuvant chemotherapy course for node-negative breast cancer: five-year results of trial V. International Breast Cancer Study Group (formerly Ludwig Group).
Journal of the National Cancer Institute. Monographs 1992;(11):89-96.
1992: Hürny C; Bernhard J; Gelber R D; Coates A; Castiglione M; Isley M; Dreher D; Peterson H; Goldhirsch A; Senn H J
Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. The International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1992;28(1):118-24.
1992: Gelber R D; Goldhirsch A
Reporting and interpreting adjuvant therapy clinical trials. International Breast Cancer Study Group (formerly Ludwig Group).
Journal of the National Cancer Institute. Monographs 1992;(11):59-69.
1992: Gelber R D; Goldhirsch A; Hürny C; Bernhard J; Simes R J
Quality of life in clinical trials of adjuvant therapies. International Breast Cancer Study Group (formerly Ludwig Group).
Journal of the National Cancer Institute. Monographs 1992;(11):127-35.
1992: Grier H E; Gelber R D; Link M P; Camitta B P; Clavell L A; Weistein H J
Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6 Suppl 2():48-51.
1992: Gelber R D; Goldhirsch A
Models for weighing benefits and toxicities.
Cancer treatment and research 1992;60():189-206.
1991: Niemeyer C M; Gelber R D; Tarbell N J; Donnelly M; Clavell L A; Blattner S R; Donahue K; Cohen H J; Sallan S E
Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update).
Blood 1991;78(10):2514-9.
1991: Niemeyer C M; Reiter A; Riehm H; Donnelly M; Gelber R D; Sallan S E
Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):745-9.
1991: Taylor C W; Anbazhagan R; Jayatilake H; Adams A; Gusterson B A; Price K; Gelber R D; Goldhirsch A
Helix pomatia in breast cancer.
Lancet 1991;338(8766):580-1.
1991: Gelber R D; Goldhirsch A
Meta-analysis: the fashion of summing-up evidence. Part I. Rationale and conduct.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(7):461-8.
1991: Neville A M; Price K N; Gelber R D; Goldhirsch A
Axillary node micrometastases and breast cancer.
Lancet 1991;337(8749):1110.
1991: Gelber R D; Goldhirsch A; Cavalli F
Quality-of-life-adjusted evaluation of adjuvant therapies for operable breast cancer. The International Breast Cancer Study Group.
Annals of internal medicine 1991;114(8):621-8.
1991: Lipshultz S E; Colan S D; Gelber R D; Perez-Atayde A R; Sallan S E; Sanders S P
Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood.
The New England journal of medicine 1991;324(12):808-15.
1991: Anbazhagan R; Gelber R D; Bettelheim R; Goldhirsch A; Gusterson B A
Association of c-erbB-2 expression and S-phase fraction in the prognosis of node positive breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(1):47-53.
1991: Goldhirsch A; Gelber R D; Castiglione M
Adjuvant therapy of breast cancer. International Breast Cancer Study Group.
European journal of cancer (Oxford, England : 1990) 1991;27(3):389-99.
1990: Sonis A L; Tarbell N; Valachovic R W; Gelber R; Schwenn M; Sallan S
Dentofacial development in long-term survivors of acute lymphoblastic leukemia. A comparison of three treatment modalities.
Cancer 1990;66(12):2645-52.
1990: Byar D P; Schoenfeld D A; Green S B; Amato D A; Davis R; De Gruttola V; Finkelstein D M; Gatsonis C; Gelber R D; Lagakos S
Design considerations for AIDS trials.
The New England journal of medicine 1990;323(19):1343-8.
1990: Longmore G; Guinan E C; Weinstein H J; Gelber R D; Rappeport J M; Antin J H
Bone marrow transplantation for myelodysplasia and secondary acute nonlymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(10):1707-14.
1990: Neville A M; Bettelheim R; Gelber R D; Goldhirsch A
Occult axillary lymph-node micrometastases in breast cancer.
Lancet 1990;336(8717):759.
1990: Goldhirsch A; Gelman R S; Gelber R D; Castiglione M
Treatment of breast cancer in elderly patients.
Lancet 1990;336(8714):564.
1990: Richner J; Gerber H A; Locher G W; Goldhirsch A; Gelber R D; Gullick W J; Berger M S; Groner B; Hynes N E
c-erbB-2 protein expression in node negative breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(4):263-8.
1990: Goldhirsch A; Castiglione M; Gelber R D
Adjuvant chemo-endocrine therapy in postmenopausal women with breast cancer and axillary-node metastases.
Lancet 1990;335(8697):1099-100.
1990: Castiglione M; Gelber R D; Goldhirsch A
Adjuvant systemic therapy for breast cancer in the elderly: competing causes of mortality. International Breast Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):519-26.
1990: Waber D P; Urion D K; Tarbell N J; Niemeyer C; Gelber R; Sallan S E
Late effects of central nervous system treatment of acute lymphoblastic leukemia in childhood are sex-dependent.
Developmental medicine and child neurology 1990;32(3):238-48.
1990: Gelman R; Gelber R; Henderson I C; Coleman C N; Harris J R
Improved methodology for analyzing local and distant recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(3):548-55.
1990: Goldhirsch A; Gelber R D; Castiglione M
The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(3):183-8.
1990: Sallan S E; Gelber R D; Kimball V; Donnelly M; Cohen H J
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.
Haematology and blood transfusion 1990;33():459-66.
1990: Grier H E; Gelber R D; Clavell L A; Camitta B M; Link M P; Garcea M J; Weinstein H J
Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Haematology and blood transfusion 1990;33():193-7.
1989: Sallan S E; Niemeyer C M; Billett A L; Lipton J M; Tarbell N J; Gelber R D; Murray C; Pittinger T P; Wolfe L C; Bast R C
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1594-601.
1989: Fletcher J A; Kimball V M; Lynch E; Donnelly M; Pavelka K; Gelber R D; Tantravahi R; Sallan S E
Prognostic implications of cytogenetic studies in an intensively treated group of children with acute lymphoblastic leukemia.
Blood 1989;74(6):2130-5.
1989: Gelber R D; Gelman R S; Goldhirsch A
A quality-of-life-oriented endpoint for comparing therapies.
Biometrics 1989;45(3):781-95.
1989: Gelber R D; Goldhirsch A
Clinical trials for clinicians.
Chest 1989;96(1 Suppl):97S-101S.
1989: Gelber R D; Goldhirsch A; Castiglione M
The duration of a life of quality should become the focus of "quality-of-life" studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(4):542-4.
1989: Goldhirsch A; Gelber R D; Simes R J; Glasziou P; Coates A S
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):36-44.
1989: Gelber R D; Goldhirsch A
Comparison of adjuvant therapies using quality-of-life considerations.
International journal of technology assessment in health care 1989;5(3):401-13.
1989: Goldhirsch A; Gelber R D
Randomized perioperative therapy in operable breast cancer: the Ludwig Trial V.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():43-53.
1989: Gelber R D; Goldhirsch A
Methods for assessing treatment efficacy in trials for adjuvant therapy for breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():211-9.
1989: Goldhirsch A; Gelber R D
Adjuvant chemo-endocrine therapy or endocrine therapy alone for postmenopausal patients: Ludwig Studies III and IV.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():153-62.
1988: Healy G B; Gelber R D; Trowbridge A L; Grundfast K M; Ruben R J; Price K N
Treatment of recurrent respiratory papillomatosis with human leukocyte interferon. Results of a multicenter randomized clinical trial.
The New England journal of medicine 1988;319(7):401-7.
1988: Gelber R D; Goldhirsch A
Can a clinical trial be the treatment of choice for patients with cancer?
Journal of the National Cancer Institute 1988;80(12):886-7.
1988: Hoover D L; Smith L E; Turner S J; Gelber R D; Sallan S E
Ophthalmic evaluation of survivors of acute lymphoblastic leukemia.
Ophthalmology 1988;95(2):151-5.
1988: Gelber R D; Goldhirsch A
Meta-analysis in clinical research.
Annals of internal medicine 1988;108(1):158-9.
1988: Goldhirsch A; Gelber R D; Castiglione M
Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(1):89-97.
1987: Hedley D W; Rugg C A; Gelber R D
Association of DNA index and S-phase fraction with prognosis of nodes positive early breast cancer.
Cancer research 1987;47(17):4729-35.
1987: Kramer S; Gelber R D; Snow J B; Marcial V A; Lowry L D; Davis L W; Chandler R
Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group.
Head & neck surgery 1987;10(1):19-30.
1987: Grier H E; Gelber R D; Camitta B M; Delorey M J; Link M P; Price K N; Leavitt P R; Weinstein H J
Prognostic factors in childhood acute myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(7):1026-32.
1987: Goldhirsch A; Gelber R D; Tattersall M N; Rudenstam C M; Cavalli F
Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer.
Lancet 1987;2(8551):151.
1987: Gelber R D; Goldhirsch A
Interpretation of results from subset analyses within overviews of randomized clinical trials.
Statistics in medicine 1987;6(3):371-88.
1987: Li F P; Gimbrere K; Gelber R D; Sallan S E; Flamant F; Green D M; Heyn R M; Meadows A T
Outcome of pregnancy in survivors of Wilms' tumor.
JAMA : the journal of the American Medical Association 1987;257(2):216-9.
1986: Gelber R D; Goldhirsch A
A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(12):1772-9.
1986: Davis B W; Gelber R D; Goldhirsch A; Hartmann W H; Locher G W; Reed R; Golouh R; Säve-Söderbergh J; Holloway L; Russell I
Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.
Cancer 1986;58(12):2662-70.
1986: Gelber R D; Goldhirsch A
The concept of an overview of cancer clinical trials with special emphasis on early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(11):1696-703.
1986: Himel H N; Liberati A; Gelber R D; Chalmers T C
Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials.
JAMA : the journal of the American Medical Association 1986;256(9):1148-59.
1986: Clavell L A; Gelber R D; Cohen H J; Hitchcock-Bryan S; Cassady J R; Tarbell N J; Blattner S R; Tantravahi R; Leavitt P; Sallan S E
Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.
The New England journal of medicine 1986;315(11):657-63.
1986: Pedrazzini A; Gelber R; Isley M; Castiglione M; Goldhirsch A
First repeated bone scan in the observation of patients with operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(3):389-94.
1986: Goldhirsch A; Gelber R
Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
NCI monographs : a publication of the National Cancer Institute 1986;(1):55-70.
1985: Davis B W; Gelber R; Goldhirsch A; Hartmann W H; Hollaway L; Russell I; Rudenstam C M
Prognostic significance of peritumoral vessel invasion in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis.
Human pathology 1985;16(12):1212-8.
1985: Goldhirsch A; Gelber R D; Cavalli F; Rudenstam C M; Tattersall M N
Adjuvant therapy in postmenopausal node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(7):1045-7.
1985: Goldhirsch A; Gelber R D; Tattersall M N; Rudenstam C M; Cavalli F
Endocrine adjuvant therapy for breast cancer.
Lancet 1985;1(8440):1274.
1985: Goorin A M; Hershey B J; Levin M J; Siber G R; Gelber R D; Flynn K; Lew M; Beckett K; Blanding P; Sallan S E
Use of trimethoprim-sulfamethoxazole to prevent bacterial infections in children with acute lymphoblastic leukemia.
Pediatric infectious disease 1985;4(3):265-9.
1985: Rominger C J; Gunderson L L; Gelber R D; Conner N
Radiation therapy alone or in combination with chemotherapy in the treatment of residual or inoperable carcinoma of the rectum and rectosigmoid or pelvic recurrence following colorectal surgery. Radiation Therapy Oncology Group study (76-16).
American journal of clinical oncology 1985;8(2):118-27.
1985: Gelber R D
Methodological and statistical aspects in perioperative chemotherapy trials.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1985;98():53-63.
1984: Goorin A M; Delorey M J; Lack E E; Gelber R D; Price K; Cassady J R; Levey R; Tapper D; Jaffe N; Link M
Prognostic significance of complete surgical resection of pulmonary metastases in patients with osteogenic sarcoma: analysis of 32 patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1984;2(5):425-31.
1984: Gelber R D
Ludwig Breast Cancer trial LBCS III: chemo- and endocrine adjuvant treatment in postmenopausal patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;96():102-9.
1983: Li F P; Yan J C; Sallan S; Cassady J R; Danahy J; Fine W; Gelber R D; Green D M
Second neoplasms after Wilms' tumor in childhood.
Journal of the National Cancer Institute 1983;71(6):1205-9.
1982: Taylor S G; Gelber R D
Experience of the Eastern Cooperative Oncology Group with doxorubicin as a single agent in patients with previously untreated breast cancer.
Cancer treatment reports 1982;66(7):1594-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Richard Gelber

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Richard Gelber (preview)

All Publications